Foundational Science and Mechanisms of Disease

A 65-year-old male with a history of symptomatic atrial fibrillation presents to the cardiology clinic to optimize his medical regimen. The physician decides to start an oral antiarrhythmic agent to maintain normal sinus rhythm. The selected drug has the following known pharmacokinetic parameters in this patient demographic:

* Volume of distribution ($V_d$): $40$ L
* Systemic clearance ($CL$): $2.5$ L/hr
* Oral bioavailability ($F$): $0.80$ ($80\%$)
* Half-life ($t_{1/2}$): $11.1$ hours

The target average steady-state plasma concentration ($C_{ss}$) for optimal efficacy without toxicity is $4.0$ mg/L. The physician plans to prescribe the medication to be taken orally every $12$ hours.

Based on these pharmacokinetic parameters, what is the appropriate single oral maintenance dose that should be administered every $12$ hours?

During morning rounds on the oncology service, a 71-year-old hospitalized individual is found profoundly lethargic and diaphoric. The patient was admitted two days ago for a core needle biopsy of a massive right-sided pleural mass that occupies the lower two-thirds of the hemithorax. Point-of-care capillary blood glucose is 32 mg/dL. A stat venous blood draw is obtained before the administration of intravenous dextrose, which rapidly restores the patient's normal sensorium. The laboratory results from the hypoglycemic episode return as follows:

Plasma glucose: 35 mg/dL
Serum insulin: < 1.0 µU/mL (Normal: 3-25 µU/mL)
Serum C-peptide: 0.1 ng/mL (Normal: 1.1-4.4 ng/mL)
Serum beta-hydroxybutyrate: 0.1 mmol/L (Normal: < 0.4 mmol/L)
Serum growth hormone (GH): < 0.1 ng/mL (Normal: 0.4-10 ng/mL)
Serum insulin-like growth factor 1 (IGF-1): 22 ng/mL (Normal: 70-250 ng/mL)

Which of the following cellular or biochemical mechanisms best explains this patient's clinical presentation and laboratory profile?

Match each patient's clinical presentation with the specific host cell receptor targeted by the responsible viral pathogen.

Following a recent medical mission in Southeast Asia where she sustained an accidental needlestick injury, a 24-year-old woman develops progressive fatigue, right upper quadrant abdominal pain, and dark urine. Physical examination confirms marked scleral icterus and a tender, palpable liver edge. Laboratory studies reveal severely elevated aspartate aminotransferase (AST) and alanine aminotransferase (ALT), alongside positive serologies for Hepatitis B surface antigen (HBsAg) and IgM anti-HBc. A liver biopsy is obtained to evaluate the extent of injury, demonstrating scattered shrunken, intensely eosinophilic cells with fragmented nuclei, known as Councilman bodies. The targeted elimination of these infected hepatocytes is primarily driven by cytotoxic T lymphocytes.

Arrange the following subcellular events in the correct chronological sequence that leads to the specific histological findings described in this patient's liver biopsy.

A 42-year-old woman is evaluated for a recurrence of high-grade serous ovarian carcinoma. She has a strong family history of breast and ovarian malignancies and is known to carry a deleterious germline mutation in the BRCA1 gene. Her oncologist initiates therapy with olaparib, an oral targeted agent that exploits the principle of synthetic lethality. Arrange the following molecular and cellular events in the correct chronological sequence that mediates the antineoplastic efficacy of this pharmacological intervention.

A 48-year-old woman is admitted to the hospital with a massive left iliofemoral deep vein thrombosis. She is immediately started on an intravenous infusion of unfractionated heparin, and oral warfarin is initiated on the same day. Her past medical history is significant for two prior unprovoked lower extremity deep vein thromboses in her 30s. On hospital day 3, she complains of severe pain over her anterior thighs and abdomen. Physical examination reveals several large, well-demarcated, erythematous plaques that rapidly progress to purpuric, necrotic eschars over the next 12 hours. Laboratory studies show a platelet count of 245,000/mm³ (baseline 250,000/mm³), a prothrombin time (PT) of 22 seconds, and an activated partial thromboplastin time (aPTT) of 65 seconds. Which of the following underlying conditions most strongly predisposed this patient to develop this specific cutaneous complication?

A $76$-year-old man is brought to the emergency department by his daughter after he vomited approximately $500$ mL of bright red blood. He has a history of nonvalvular atrial fibrillation, hypertension, and osteoarthritis. His medications include dabigatran, lisinopril, and ibuprofen. For the past $3$ days, he has had a diarrheal illness with poor oral intake. On presentation, he appears pale and diaphoretic. Blood pressure is $86/54$ mm Hg, and pulse is $118$/min.

Laboratory results are as follows:
- Hemoglobin: $7.2$ g/dL
- Platelet count: $210,000$/mm $^3$
- Creatinine: $3.4$ mg/dL (baseline $1.2$ mg/dL)
- Prothrombin time (PT): $16$ seconds
- Activated partial thromboplastin time (aPTT): $72$ seconds

The patient is given intravenous crystalloids and packed red blood cells. A specific pharmacologic antidote is administered to rapidly neutralize the circulating anticoagulant. Which of the following best describes the mechanism of action of this antidote?

A 58-year-old man is hospitalized for an acute myocardial infarction and undergoes percutaneous coronary intervention. He receives an unfractionated heparin infusion as bridging therapy. On hospital day 7, his platelet count falls precipitously from 260,000/mm³ to 85,000/mm³. Concurrently, he complains of acute, severe pain in his left lower extremity, and a venous Doppler ultrasound confirms a new deep vein thrombosis. The patient's 4T score indicates a high clinical probability of heparin-induced thrombocytopenia (HIT). Arrange the following therapeutic management steps in the correct chronological sequence.

A 28-year-old aid worker recently returned from a disaster relief mission in Southeast Asia. She presents to the emergency department with severe, voluminous watery diarrhea and muscle cramps that began 12 hours ago. Her vital signs show a blood pressure of 86/50 mmHg, heart rate of 124/min, and a respiratory rate of 22/min. Physical examination reveals deeply sunken eyes, dry mucous membranes, and delayed capillary refill. Stool is liquid, pale, and flecked with small amounts of mucus. She is aggressively rehydrated with intravenous crystalloids. The pathogen responsible for this patient's condition exerts its effect through a specific multi-step cellular cascade.

Arrange the following events in the correct chronological order to describe the cellular mechanism of action of the primary enterotoxin produced by the most likely causative organism.

A clinical pharmacologist is reviewing medication charts for several patients admitted to the internal medicine service. Various drug-related changes in efficacy, toxicity, and duration of action are noted. Identify the underlying pharmacokinetic or pharmacodynamic mechanism that best explains each patient's clinical presentation.

A 51-year-old man is evaluated in the outpatient clinic for an 8-month history of progressive proximal muscle weakness and diffuse bone pain. He reports difficulty climbing stairs and rising from a chair. He recently sustained a right-sided rib fracture from a minor coughing fit. His medical history is significant for gastroesophageal reflux disease, for which he frequently takes over-the-counter aluminum hydroxide. He took a short course of oral bisphosphonates 2 years ago for suspected osteoporosis but discontinued it. Vital signs are within normal limits. Physical examination reveals proximal muscle weakness of the lower extremities and marked tenderness over the ribs, pelvis, and shins.

Laboratory studies show the following:

Urinalysis reveals a fractional excretion of phosphate of 25% (normal < 5% in the setting of hypophosphatemia). Urine tests for glucose and amino acids are negative.

Which of the following is the most likely primary molecular mechanism responsible for this patient's clinical and laboratory findings?

A 42-year-old man presents to the clinic with progressive shortness of breath on exertion and a chronic daily cough. He has a 10-pack-year smoking history but quit 5 years ago. Pulmonary function testing demonstrates an obstructive pattern with a decreased diffusing capacity of the lungs for carbon monoxide (DLCO). Routine laboratory evaluation reveals mildly elevated serum aminotransferases. A subsequent liver biopsy is performed, revealing periodic acid-Schiff (PAS)-positive, diastase-resistant globules in the cytoplasm of periportal hepatocytes. If the accumulated substance in this patient's hepatocytes continues to overwhelm the cellular degradative capacity, which of the following mechanisms will most likely mediate the subsequent cell death?

A $34$-year-old man is brought to the emergency department by emergency medical services after being found unresponsive in a public restroom. On initial evaluation, his respiratory rate is $6/\text{min}$ and he has pinpoint pupils. He is administered intravenous naloxone, which rapidly improves his respiratory effort and mental status. The patient admits to injecting heroin earlier in the day and expresses a strong desire to enter treatment for his substance use. After observing the patient for $2$ hours, the physician notes that he appears calm with stable vital signs and minimal objective signs of withdrawal. To initiate medication-assisted treatment for opioid use disorder before discharge, the physician administers a dose of sublingual buprenorphine. Within $20$ minutes, the patient becomes extremely agitated, diaphoretic, and tachycardic. He complains of severe diffuse muscle aches, nausea, and abdominal cramps. Which of the following pharmacodynamic properties of the newly administered medication best explains this patient's acute deterioration?

Pathologic changes at the cellular level present uniquely depending on the inciting stressor and the specific tissue involved. Match each patient's clinical and pathologic presentation with the underlying cellular injury or adaptation mechanism responsible for the observed findings.

A 76-year-old man with a 25-year history of poorly controlled essential hypertension and osteoarthritis dies from complications of a massive subarachnoid hemorrhage. Postmortem examination reveals a markedly enlarged heart with concentric left ventricular thickening. Light microscopy of the myocardium demonstrates widened myocytes containing enlarged, hyperchromatic 'boxcar' nuclei. High-power examination of these cells reveals the presence of a finely granular, yellow-brown perinuclear pigment. This pigment is strongly positive for Sudan Black B and periodic acid-Schiff (PAS) staining, but it is negative for Prussian blue staining. Which of the following pathophysiologic processes is most directly responsible for the accumulation of this intracellular material?

A 42-year-old man with no history of tobacco use is referred to a pulmonologist for progressive exertional dyspnea that has worsened over the past two years. Pulmonary function tests demonstrate an obstructive pattern that does not improve with inhaled bronchodilators. High-resolution computed tomography of the chest reveals widespread emphysematous changes predominantly affecting the lower lung zones. A comprehensive metabolic panel is notable for mildly elevated aspartate and alanine aminotransferases. To further evaluate the liver abnormalities, a percutaneous liver biopsy is performed. Microscopic examination of the tissue reveals round, eosinophilic globules within the cytoplasm of periportal hepatocytes. These inclusions stain intensely with periodic acid-Schiff (PAS) and resist digestion with diastase. Which of the following best describes the fundamental cellular mechanism responsible for the hepatocyte inclusions seen in this patient?

Match each patient's clinical and laboratory presentation with the specific underlying pathophysiological or molecular mechanism responsible for their hypercoagulable state.

A 71-year-old man with a history of a mechanical aortic valve replacement presents to the hospital with two weeks of low-grade fever, fatigue, and night sweats. Physical examination reveals a new early diastolic murmur and small, tender erythematous nodules on the pads of his fingers. Transesophageal echocardiography demonstrates an oscillating 0.8-cm vegetation on the prosthetic valve. Multiple blood cultures grow *Enterococcus faecalis*. Susceptibility testing indicates the isolate is susceptible to ampicillin but demonstrates high-level resistance to gentamicin. Consequently, the planned synergistic regimen of ampicillin and gentamicin is abandoned, and he is treated with ampicillin and ceftriaxone. Which of the following best describes the molecular mechanism responsible for this isolate's high-level resistance to gentamicin?

A 67-year-old man is hospitalized in the intensive care unit for ventilator-associated pneumonia. Initial endotracheal aspirate cultures grow *Pseudomonas aeruginosa* that is susceptible to piperacillin-tazobactam, cefepime, ciprofloxacin, and imipenem. The patient is started on intravenous imipenem-cilastatin. He initially improves, but on day 11 of hospitalization, his respiratory status declines, and he requires an increase in ventilator support. His temperature is 38.9°C (102°F), blood pressure is 100/60 mm Hg, and pulse is 110/min. A repeat endotracheal aspirate culture again grows *Pseudomonas aeruginosa*. Susceptibility testing of the new isolate reveals resistance to imipenem, but continued susceptibility to cefepime, piperacillin-tazobactam, and ciprofloxacin. Which of the following is the most likely mechanism for the rapid emergence of antimicrobial resistance in this patient's infection?

Match each clinical scenario of antimicrobial treatment failure with the primary molecular or cellular mechanism responsible for the pathogen's resistance.